Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,498 | 756 | 15,699 | 2,885 | 3,542 |
| Cost of Goods | 3,639 | 3,333 | 2,800 | 1,780 | 2,034 |
| Gross Profit | -2,141 | -2,577 | 12,899 | 1,105 | 1,508 |
| Operating Expenses | 28,495 | 21,144 | 19,280 | 21,088 | 17,618 |
| Operating Income | -29,997 | -23,388 | -5,581 | -19,203 | -16,076 |
| Interest Expense | 0 | 0 | 0 | 0 | 10 |
| Other Income | -5,498 | 3,861 | 3,513 | 9,860 | 2,590 |
| Pre-tax Income | -35,495 | -19,527 | -2,068 | -9,343 | -13,496 |
| Income Tax | 49 | 228 | 244 | 9,022 | -3,052 |
| Net Income Continuous | -35,544 | -19,755 | -2,312 | -18,365 | -10,444 |
| Net Income | $-35,544 | $-19,755 | $-2,312 | $-18,365 | $-10,444 |
| EPS Basic Total Ops | -0.75 | -0.42 | -0.06 | -0.47 | -0.28 |
| EPS Basic Continuous Ops | -0.76 | -0.42 | -0.05 | -0.48 | -0.28 |
| EPS Diluted Total Ops | -0.75 | -0.42 | -0.06 | -0.47 | -0.28 |
| EPS Diluted Continuous Ops | -0.76 | -0.42 | -0.05 | -0.48 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.75 | -0.42 | -0.05 | N/A | N/A |
| EBITDA(a) | $-29,846 | $-23,238 | $-5,429 | $-19,060 | $-15,914 |